1411 related articles for article (PubMed ID: 8842346)
21. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system].
Goto K; Osuga K; Haga K; Tsumagari T
Nihon Yakurigaku Zasshi; 1983 May; 81(5):343-63. PubMed ID: 6629211
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
[TBL] [Abstract][Full Text] [Related]
23. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
[TBL] [Abstract][Full Text] [Related]
24. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
[TBL] [Abstract][Full Text] [Related]
25. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
[TBL] [Abstract][Full Text] [Related]
26. General pharmacology of the non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Hayashi M; Kajiwara Y; Kitabatake K; Uruno T; Kubota K
Arzneimittelforschung; 1993 Nov; 43(11):1169-74. PubMed ID: 8292059
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive and general pharmacological properties of budralazine.
Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
[TBL] [Abstract][Full Text] [Related]
28. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F
Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381
[TBL] [Abstract][Full Text] [Related]
29. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile of the new antidepressant levoprotiline.
Noguchi S; Okada M; Inukai T
Arzneimittelforschung; 1992 Jun; 42(6):787-94. PubMed ID: 1418032
[TBL] [Abstract][Full Text] [Related]
31. [General pharmacology of T-1982, a new cephamycin antibiotic].
Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Arai H; Omori M; Tanada K; Senda N; Hashiba K; Matsukura K; Takata K; Okami H
Jpn J Antibiot; 1982 Sep; 35(9):2139-54. PubMed ID: 7143714
[TBL] [Abstract][Full Text] [Related]
32. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
Shibata K; Mita I; Shinoda Y; Nakano U; Kinoshita H; Noguchi M; Uzawa T; Sohmiya Y; Takayanagi N
Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
[TBL] [Abstract][Full Text] [Related]
33. [General pharmacology of T-2588, a new oral cephem antibiotic].
Hirai S; Kodama T; Hiraiwa T; Abe N; Arai H; Ono S; Omori M; Nakada Y; Hashiba K; Tanada K
Jpn J Antibiot; 1986 Apr; 39(4):958-78. PubMed ID: 3761550
[TBL] [Abstract][Full Text] [Related]
34. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
[TBL] [Abstract][Full Text] [Related]
35. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
37. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)].
Ochiai T; Fukuchi I; Ego H; Yamamura M; Kudo Y; Ishida R
Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456
[TBL] [Abstract][Full Text] [Related]
38. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112).
Märki F; Büch O; Delini-Stula A; Kraetz J; Petermann H; Radeke E; Schweizer A; Thomann P; Truog A
Arzneimittelforschung; 1984; 34(3):247-52. PubMed ID: 6539603
[TBL] [Abstract][Full Text] [Related]
39. General pharmacology studies on recombinant human follicle stimulating hormone.
Biffoni M; Cantelmo A; Marcucci I; Martelli F; Suzuki H; Borrelli F; Suzuki K
Arzneimittelforschung; 1994 Sep; 44(9):1096-102. PubMed ID: 7986251
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacological studies on oxatomide: (6) Effect on the peripheral organs].
Ohmori K; Ishii H; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):79-104. PubMed ID: 6133821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
